Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts
Article in Cancers (March 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Cancers (March 2024)
Article in International Journal of Molecular Sciences (November 2023)
Article in Current Oncology (March 2023)